First Header Logo Second Header Logo

Connection

Steven Feldman to Medication Adherence

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Medication Adherence.
Steven Feldman
Connection Strength
20.393
Medication Adherence
  1. Bray JK, Feldman SR. The ethical implications of utilizing advertising techniques to increase biologic treatment willingness in patients with psoriasis. Dermatol Online J. 2020 Jul 15; 26(7).
    View in: PubMed
    Score: 0.620
  2. Okwundu N, Cardwell LA, Cline AE, Richardson IM, Feldman SR. Adherence to topical treatment can improve treatment-resistant moderate psoriasis. Cutis. 2020 Feb; 105(2):89-91;E2;E3.
    View in: PubMed
    Score: 0.601
  3. Johnson MC, Pona A, Adler-Neal AL, Kesty C, Cline A, Feldman SR. Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers' Willingness to Use Corticosteroids: A Randomized Controlled Trial [Formula: see text]. J Cutan Med Surg. 2020 Jan/Feb; 24(1):17-22.
    View in: PubMed
    Score: 0.581
  4. Payne J, Habet KA, Pona A, Feldman SR. A Review of Topical Corticosteroid Foams J Drugs Dermatol. 2019 Aug 01; 18(8):756-770.
    View in: PubMed
    Score: 0.580
  5. Curry ZA, Johnson MC, Unrue EL, Feldman SR. Caregiver willingness to treat atopic dermatitis is not much improved by anchoring. J Dermatolog Treat. 2019 Aug; 30(5):471-474.
    View in: PubMed
    Score: 0.554
  6. Aung-Din D, Sahni DR, Jorizzo JL, Feldman SR. Morgellons disease: insights into treatment. Dermatol Online J. 2018 Nov 15; 24(11).
    View in: PubMed
    Score: 0.552
  7. Seale L, Cardwell LA, Feldman SR. Adherence to biologics in patients with psoriasis. Expert Rev Clin Immunol. 2018 02; 14(2):155-161.
    View in: PubMed
    Score: 0.521
  8. Lewis DJ, Feldman SR. Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroids. Pediatr Dermatol. 2018 Mar; 35(2):278-279.
    View in: PubMed
    Score: 0.520
  9. Oussedik E, Cardwell LA, Patel NU, Onikoyi O, Feldman SR. An Anchoring-Based Intervention to Increase Patient Willingness to Use Injectable Medication in Psoriasis. JAMA Dermatol. 2017 09 01; 153(9):932-934.
    View in: PubMed
    Score: 0.508
  10. Patel NU, D'Ambra V, Feldman SR. Increasing Adherence with Topical Agents for Atopic Dermatitis. Am J Clin Dermatol. 2017 Jun; 18(3):323-332.
    View in: PubMed
    Score: 0.499
  11. Feldman SR, Vrijens B, Gieler U, Piaserico S, Puig L, van de Kerkhof P. Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence. Am J Clin Dermatol. 2017 Apr; 18(2):253-271.
    View in: PubMed
    Score: 0.493
  12. Patel N, Feldman SR. Adherence in Atopic Dermatitis. Adv Exp Med Biol. 2017; 1027:139-159.
    View in: PubMed
    Score: 0.485
  13. Ahn CS, Culp L, Huang WW, Davis SA, Feldman SR. Adherence in dermatology. J Dermatolog Treat. 2017 Mar; 28(2):94-103.
    View in: PubMed
    Score: 0.464
  14. Hill D, Farhangian ME, Feldman SR. Increasing adherence to topical therapy in psoriasis through use of solution medication. Dermatol Online J. 2016 May 15; 22(5).
    View in: PubMed
    Score: 0.464
  15. Feldman SR, Anderson K. In Reply. JAMA Dermatol. 2015 Oct; 151(10):1145.
    View in: PubMed
    Score: 0.445
  16. Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of Primary Nonadherence to Acne Treatment. JAMA Dermatol. 2015 Jun; 151(6):623-6.
    View in: PubMed
    Score: 0.435
  17. Farhangian ME, Feldman SR. Moving Away from Fee-for-Service: Implications for Medication Adherence. South Med J. 2015 May; 108(5):298-9.
    View in: PubMed
    Score: 0.432
  18. Alinia H, Feldman SR. Assessing medication adherence using indirect self-report. JAMA Dermatol. 2014 Aug; 150(8):813-4.
    View in: PubMed
    Score: 0.410
  19. Bartlett KB, Davis SA, Feldman SR. Tolerability of topical antimicrobials in treatment of acne vulgaris. J Drugs Dermatol. 2014 Jun; 13(6):658-62.
    View in: PubMed
    Score: 0.405
  20. Snyder S, Crandell I, Davis SA, Feldman SR. Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol. 2014 Apr; 15(2):87-94.
    View in: PubMed
    Score: 0.401
  21. Sandoval LF, Feldman SR. Are wash outs needed in clinical trials of topical agents? J Dermatolog Treat. 2014 Feb; 25(1):1.
    View in: PubMed
    Score: 0.396
  22. Feldman SR. Disease burden and treatment adherence in psoriasis patients. Cutis. 2013 Nov; 92(5):258-63.
    View in: PubMed
    Score: 0.389
  23. Laffer MS, Feldman SR. Improving medication adherence through technology: analyzing the managing meds video challenge. Skin Res Technol. 2014 Feb; 20(1):62-6.
    View in: PubMed
    Score: 0.379
  24. Tan X, Al-Dabagh A, Davis SA, Lin HC, Balkrishnan R, Chang J, Feldman SR. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. Am J Clin Dermatol. 2013 Jun; 14(3):243-51.
    View in: PubMed
    Score: 0.378
  25. West C, Narahari S, O'Neill J, Davis S, Huynh M, Clark A, Boles A, Feldman SR. Adherence to adalimumab in patients with moderate to severe psoriasis. Dermatol Online J. 2013 May 15; 19(5):18182.
    View in: PubMed
    Score: 0.377
  26. Heaton E, Levender MM, Feldman SR. Timing of office visits can be a powerful tool to improve adherence in the treatment of dermatologic conditions. J Dermatolog Treat. 2013 Apr; 24(2):82-8.
    View in: PubMed
    Score: 0.371
  27. Fenerty SD, O'Neill JL, Gustafson CJ, Feldman SR. Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol. 2013 Feb; 149(2):229-31.
    View in: PubMed
    Score: 0.370
  28. Kosari P, Feldman SR. Letter: Treatment-resistant pyoderma gangrenosum. Dermatol Online J. 2012 Apr 15; 18(4):8.
    View in: PubMed
    Score: 0.350
  29. Luersen K, Davis SA, Kaplan SG, Abel TD, Winchester WW, Feldman SR. Sticker charts: a method for improving adherence to treatment of chronic diseases in children. Pediatr Dermatol. 2012 Jul-Aug; 29(4):403-8.
    View in: PubMed
    Score: 0.349
  30. Dabade TS, Feldman SR. We must think outside the box to understand nonadherence. Pediatr Dermatol. 2011 May-Jun; 28(3):353.
    View in: PubMed
    Score: 0.327
  31. Feldman SR. Perhaps programs are a better way to go. J Dermatolog Treat. 2010 Nov; 21(6):325.
    View in: PubMed
    Score: 0.316
  32. Rajpara AN, Feldman SR. Adherence to treatment: still the forgotten variable. Arch Dermatol. 2010 Oct; 146(10):1183-4; author reply 1184.
    View in: PubMed
    Score: 0.314
  33. Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, Feldman SR. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010 Oct; 86(4):208-13.
    View in: PubMed
    Score: 0.314
  34. Lott R, Taylor SL, O'Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010 Jun; 9(2):160-6.
    View in: PubMed
    Score: 0.307
  35. Greenlaw SM, Yentzer BA, O'Neill JL, Balkrishnan R, Feldman SR. Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol. 2010 May; 16(2):253-8.
    View in: PubMed
    Score: 0.305
  36. Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol. 2010 Apr; 9(4):324-9.
    View in: PubMed
    Score: 0.304
  37. Ntuen E, Taylor SL, Kinney M, O'Neill JL, Krowchuk DP, Feldman SR. Physicians' perceptions of an eczema action plan for atopic dermatitis. J Dermatolog Treat. 2010 Jan; 21(1):28-33.
    View in: PubMed
    Score: 0.299
  38. Nolan BV, Feldman SR. Dermatologic medication adherence. Dermatol Clin. 2009 Apr; 27(2):113-20, v.
    View in: PubMed
    Score: 0.283
  39. Feldman SR. Improving adherence to topical treatment. Cutis. 2009 Apr; 83(4):215-7.
    View in: PubMed
    Score: 0.283
  40. Yentzer B, Hick J, Williams L, Inabinet R, Wilson R, Camacho FT, Russell GB, Feldman SR. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses. Arch Dermatol. 2009 Feb; 145(2):203-5.
    View in: PubMed
    Score: 0.280
  41. Feldman SR. Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis? J Dermatolog Treat. 2009; 20(6):317-8.
    View in: PubMed
    Score: 0.279
  42. Payne JE, Ghamrawi RI, Lin IJ, Feldman SR. Utilization of an Online Cash-Pay Pharmacy for Topical 5-Fluorouracil Prescriptions in Older Patients. J Drugs Dermatol. 2020 May 01; 19(5):539-542.
    View in: PubMed
    Score: 0.153
  43. Bashyam AM, Cuellar-Barboza A, Masicampo EJ, Feldman SR. Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use. J Am Acad Dermatol. 2020 Dec; 83(6):1773-1775.
    View in: PubMed
    Score: 0.152
  44. Balogh EA, Bashyam AM, Ghamrawi RI, Feldman SR. Emerging systemic drugs in the treatment of plaque psoriasis. Expert Opin Emerg Drugs. 2020 06; 25(2):89-100.
    View in: PubMed
    Score: 0.152
  45. Cohen SR, Haidari W, Feldman SR. Why aren't they using their medicine? Pediatr Dermatol. 2020 01; 37(1):62-63.
    View in: PubMed
    Score: 0.149
  46. Feldman SR, Zhang J, Martinez DJ, Lopez-Gonzalez L, Marchlewicz EH, Shrady G, Mendelsohn AM, Zhao Y. Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status. J Dermatolog Treat. 2021 Mar; 32(2):203-211.
    View in: PubMed
    Score: 0.149
  47. Habet KA, Kolli SS, Pona A, Feldman SR. A review of topical corticosteroid sprays for the treatment of inflammatory dermatoses. Dermatol Online J. 2019 Aug 15; 25(8).
    View in: PubMed
    Score: 0.145
  48. Feldman SR, Pelletier CL, Wilson KL, Mehta RK, Brouillette MA, Smith D, Bonafede MM. Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis. J Comp Eff Res. 2019 07; 8(9):699-709.
    View in: PubMed
    Score: 0.143
  49. Glines KR, Stiff KM, Freeze M, Cline A, Strowd LC, Feldman SR. An update on the topical and oral therapy options for treating pediatric atopic dermatitis. Expert Opin Pharmacother. 2019 04; 20(5):621-629.
    View in: PubMed
    Score: 0.139
  50. Hogue L, Cardwell LA, Roach C, Felix KH, Oussedik E, Richardson I, Feldman SR. Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray. J Cutan Med Surg. 2019 Mar/Apr; 23(2):157-163.
    View in: PubMed
    Score: 0.139
  51. Aleshaki JS, Cardwell LA, Muse ME, Feldman SR. Adherence and resource use among psoriasis patients treated with biologics. Expert Rev Pharmacoecon Outcomes Res. 2018 12; 18(6):609-617.
    View in: PubMed
    Score: 0.136
  52. Heath MS, Sahni DR, Curry ZA, Feldman SR. Pharmacokinetics of tazarotene and acitretin in psoriasis. Expert Opin Drug Metab Toxicol. 2018 Sep; 14(9):919-927.
    View in: PubMed
    Score: 0.136
  53. Ro T, Tull RZ, Cardwell LA, Farhangian ME, Moustafa F, Richardson I, Jorizzo JL, Feldman S, Huang W. A Pilot Study Characterizing Factors in Adherence to Cutaneous Lupus Treatment. J Cutan Med Surg. 2018 Sep/Oct; 22(5):530-532.
    View in: PubMed
    Score: 0.136
  54. Nadkarni A, Saleem MD, Feldman SR. Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization. J Drugs Dermatol. 2017 Aug 01; 16(8):755-758.
    View in: PubMed
    Score: 0.126
  55. Hawkins SD, Barilla S, Feldman SR. Web app based patient education in psoriasis - a randomized controlled trial. Dermatol Online J. 2017 Apr 15; 23(4).
    View in: PubMed
    Score: 0.124
  56. Vale SM, Hill D, Feldman SR. Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update. Pharmacoeconomics. 2017 02; 35(2):177-190.
    View in: PubMed
    Score: 0.122
  57. Smith JA, Narahari S, Hill D, Feldman SR. Tazarotene foam, 0.1%, for the treatment of acne. Expert Opin Drug Saf. 2016 Jan; 15(1):99-103.
    View in: PubMed
    Score: 0.112
  58. Hester C, Park C, Chung J, Balkrishnan R, Feldman S, Chang J. Medication Adherence in Children and Adolescents with Acne Vulgaris in Medicaid: A Retrospective Study Analysis. Pediatr Dermatol. 2016 Jan-Feb; 33(1):49-55.
    View in: PubMed
    Score: 0.112
  59. Vaidya TS, Anderson KL, Feldman SR. Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity. Dermatol Online J. 2015 Sep 17; 21(9).
    View in: PubMed
    Score: 0.111
  60. Kuo S, Huang KE, Davis SA, Feldman SR. The rosacea patient journey: a novel approach to conceptualizing patient experiences. Cutis. 2015 Jan; 95(1):37-43.
    View in: PubMed
    Score: 0.106
  61. Feldman SR. Principles of topical treatment: advancement in gel vehicle technology. J Drugs Dermatol. 2014 Apr; 13(4):423-7.
    View in: PubMed
    Score: 0.100
  62. Sandoval LF, Semble A, Gustafson CJ, Huang KE, Levender MM, Feldman SR. Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients. J Drugs Dermatol. 2014 Feb; 13(2):135-40.
    View in: PubMed
    Score: 0.099
  63. Sandoval LF, Hartel JK, Feldman SR. Current and future evidence-based acne treatment: a review. Expert Opin Pharmacother. 2014 Feb; 15(2):173-92.
    View in: PubMed
    Score: 0.098
  64. Kwatra SG, Feldman SR. A dermatologist's dilemma: treatment failure or failure to treat? Cutis. 2012 Nov; 90(5):219-20.
    View in: PubMed
    Score: 0.091
  65. Martin SL, McGoey ST, Bebo BF, Feldman SR. Patients' educational needs about topical treatments for psoriasis. J Am Acad Dermatol. 2013 Jun; 68(6):e163-8.
    View in: PubMed
    Score: 0.088
  66. Feldman SR, Chen DM. How patients experience and manage dryness and irritation from acne treatment. J Drugs Dermatol. 2011 Jun; 10(6):605-8.
    View in: PubMed
    Score: 0.082
  67. Feldman SR. Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle. J Drugs Dermatol. 2010 Aug; 9(8):908-11.
    View in: PubMed
    Score: 0.078
  68. Yentzer BA, Alikhan A, Teuschler H, Williams LL, Tusa M, Fleischer AB, Kaur M, Balkrishnan R, Feldman SR. An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol. 2009 May; 60(5):879-80.
    View in: PubMed
    Score: 0.071
  69. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol. 2008 Dec; 59(6):1009-16.
    View in: PubMed
    Score: 0.068
  70. Feldman SR, Brown KL, Heald P. 'Coral reef' psoriasis: a marker of resistance to topical treatment. J Dermatolog Treat. 2008; 19(5):257-8.
    View in: PubMed
    Score: 0.065
  71. Ports WC, Feldman SR, Gupta P, Tan H, Johnson TR, Bissonnette R. Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design. J Drugs Dermatol. 2015 Aug; 14(8):777-84.
    View in: PubMed
    Score: 0.027
  72. Ou HT, Feldman SR, Balkrishnan R. Understanding and improving treatment adherence in pediatric patients. Semin Cutan Med Surg. 2010 Jun; 29(2):137-40.
    View in: PubMed
    Score: 0.019
  73. Jayawant SS, Feldman SR, Camacho FT, Yentzer B, Balkrishnan R. Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea. J Dermatolog Treat. 2008; 19(5):267-73.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.